Ipilimumab experience in heavily pretreated patients with melanoma in an expanded access program at the University Hospital of Siena (Italy)-Reference-Cited by-同舟云学术

Ipilimumab experience in heavily pretreated patients with melanoma in an expanded access program at the University Hospital of Siena (Italy)

Published:2010-12-18 Issue:4 Volume:60 Page:467-477
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Di Giacomo Anna Maria,Danielli Riccardo,Calabrò Luana,Bertocci Erica,Nannicini Chiara,Giannarelli Diana,Balestrazzi Angelo,Vigni Francesco,Riversi Valentina,Miracco Clelia,Biagioli Maurizio,Altomonte Maresa,Maio Michele

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s00262-010-0958-2.pdf

Reference37 articles.

1. Chandy BK (2006) WHO—Facts Sheet: health consequences of excessive solar UV radiation. Kuwait Med J 38:254–258

2. Tarhini AA, Agarwala SS (2006) Cutaneous melanoma: available therapy for metastatic disease. Dermatol Ther 19:19–25

3. Korn EL, Liu P-Y, Lee SJ et al (2008) Meta-analysis of phase II cooperative group trials in metastatic stage IV melanoma to determine progression-free and overall survival benchmarks for future phase II trials. J Clin OncoI 26:527–534

4. Seetharamu N, Ott PA, Pavlick AC (2009) Novel therapeutics for melanoma. Exp Rev Anticancer Ther 9:839–849

5. Bhatia S, Tykodi SS, Thompson JA (2009) Treatment of metastatic melanoma: an overview. Oncology (Williston Park) 23:488–496

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acute Oncologic Complications: Clinical–Therapeutic Management in Critical Care and Emergency Departments;Current Oncology;2023-08-02

2. Immune System in Action;Advances in Experimental Medicine and Biology;2021

3. Transcriptional Regulation of Cancer Immune Checkpoints: Emerging Strategies for Immunotherapy;Vaccines;2020-12-04

4. Clinical correlates for immune checkpoint therapy: significance for CNS malignancies;Neuro-Oncology Advances;2020-11-27

5. Diagnosis and Management of Hematological Adverse Events Induced by Immune Checkpoint Inhibitors: A Systematic Review;Frontiers in Immunology;2020-10-21